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Abstract
Background: Rho GTPases control many cellular processes, including cell survival, gene expression and migration. Rho
proteins reside mainly in the cytosol and are targeted to the plasma membrane (PM) upon specific activation by guanine
nucleotide exchange factors (GEFs). Accordingly, most GEFs are also cytosolic or associated with the PM. However, Net1, a
RhoA-specific GEF predominantly localizes to the cell nucleus at steady-state. Nuclear localization for Net1 has been seen as
a mechanism for sequestering the GEF away from RhoA, effectively rendering the protein inactive. However, considering the
prominence of nuclear Net1 and the fact that a biological stimulus that promotes Net1 translocation out the nucleus to the
cytosol has yet to be discovered, we hypothesized that Net1 might have a previously unidentified function in the nucleus of
cells.
Principal Findings: Using an affinity precipitation method to pulldown the active form of Rho GEFs from different cellular
fractions, we show here that nuclear Net1 does in fact exist in an active form, contrary to previous expectations. We further
demonstrate that a fraction of RhoA resides in the nucleus, and can also be found in a GTP-bound active form and that Net1
plays a role in the activation of nuclear RhoA. In addition, we show that ionizing radiation (IR) specifically promotes the
activation of the nuclear pool of RhoA in a Net1-dependent manner, while the cytoplasmic activity remains unchanged.
Surprisingly, irradiating isolated nuclei alone also increases nuclear RhoA activity via Net1, suggesting that all the signals
required for IR-induced nuclear RhoA signaling are contained within the nucleus.
Conclusions/Significance: These results demonstrate the existence of a functional Net1/RhoA signaling pathway within the
nucleus of the cell and implicate them in the DNA damage response.
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Introduction
Rho GTPases are a family of proteins which control many
different biological processes in the cell, including cell survival,
proliferation, adhesion, migration, gene expression and apoptosis
[1]. The Rho family of proteins contains at least 20 members, with
RhoA, Rac1 and Cdc42 being among the best characterized [1].
These proteins function as molecular switches, cycling between an
active GTP-bound form, and an inactive form that is bound to
GDP [2]. The activation state of GTPases is regulated by three
types of regulatory proteins: GEFs activate Rho proteins by
catalyzing the exchange of GDP for GTP [3]; GTPase activating
proteins (GAPs) inactivate them by promoting the intrinsic
hydrolytic activity of the proteins [4]; finally, guanine nucleotide
dissociation inhibitors (GDIs) bind to the GTPases and sequester
them within the cytosol in an inactive conformation [5].
Subcellular localization of GTPases has also been identified as
an important factor in the ability of GTPases to function in
different signaling pathways [6]. Rho GTPases are primarily
cytosolic proteins which associate with the PM via a C-terminal
prenyl group (farnesyl or geranylgeranyl), which is added
postranslationally to a C-terminal cysteine residue at the
carboxy-terminal CAAX motif. Prenylation of GTPases allows
for PM association and interaction with downstream effector
proteins [7]. GDIs function to negatively regulate Rho proteins by
extracting GTP-bound GTPases from the PM, and sequestering
them in the cytosol [5]. Similarly, most Rho-GEFs localize either
to the cytoplasm or to the PM [3]. However, at least two RhoA-
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preferentially within the nucleus at steady state [8,9]. Both Net1
and Ect2 encode nuclear localization signals (NLS) that are
required for their targeting to the nucleus [8,9,10,11]. Deletion of
the nuclear localization signals in Net1 promotes its redistribution
to the cytoplasm, with the consequent activation of RhoA and the
formation of stress fibers [8,9,10,11].
Even though many studies have suggested important biological
roles for Net1 and Ect2, it is unclear why both these GEFs are
predominantly localized to the nucleus. Since the majority of
RhoA is localized at the PM and in the cytosol of cells, the
prevailing dogma in the field of Rho signaling has been that
localization of Net1 to the nucleus is a mechanism designed to
sequester it away from RhoA, therefore rendering nuclear Net1
biologically inert [9]. This is supported by data showing that a
mutant of Net1 which is primarily cytosolic (lacking two of its
NLS) causes cellular transformation, presumably as a result of
upregulated RhoA signaling [10,11]. A logical prediction of this
hypothesis is that in order for Net1 to be functionally active, it
must be transported out of the nucleus into the cytosol, where it
can activate RhoA. However, a biological stimulus that causes
translocation of Net1 from the nucleus to the cytosol has not yet
been discovered. Considering the abundance of nuclear-localized
Net1, we hypothesized that the nuclear pool of Net1 might serve a
previously unidentified function regulating RhoA at this site.
In this study, we show that the majority of nuclear Net1 is in fact
active. We also demonstrate that a fraction of the total RhoA pool
localizes to the nucleus at steady state, and its activity is controlled
by Net1. In addition, DNA damage signals such as ionizing
radiation (IR), which has been previously shown to stimulate
RhoA, specifically promoted the activation of the nuclear pool of
RhoA in a Net1-dependent manner while the cytoplasmic activity
was not affected. This IR-mediated increase in Net1 and RhoA
activity occurred in isolated nuclei, suggesting the signals
downstream of IR originated within the nucleus. These results
represent the first demonstration that RhoA is present and can be
activated in the nucleus by a Rho GEF in response to a specific
stimulus such as IR.
Results
The RhoA-specific GEF Net1 is active in the nucleus of
cells
To determine if Net1 might be active in the nucleus we used an
assay previously developed in our laboratory to specifically
precipitate the active pool of GEFs from cell lysates [12]. This
assay takes advantage of a nucleotide-free single amino acid
mutation in RhoA (G17A) that binds with high affinity to active
RhoA-specific GEFs [12]. Since this assay had never been
performed in nuclear lysates, we optimized a nuclear isolation
protocol with emphasis on speed and purity of the isolated
fractions (see Methods). The speed of the fractionation is critical
since the efficiency of the assay decreases proportionally with time.
The purity of our isolated nuclear fractions was routinely tested by
blotting with different proteins commonly used as markers for
various cellular fractions. PM (Na
+/K
+ ATPase), endosomal
(EEA1), and cytosolic (tubulin) markers were observed in the total
lysate and post nuclear supernatant (PNS), which includes the
cytosolic and membrane fractions. Importantly, however, none of
these contaminants were observed in the nuclear fraction within
the detectable limit of these marker antibodies (Figure 1B).
Our results show that, as previously described [8,9], endogenous
Net1 is highly enriched in the nucleus, whereas other GEFs, such
as p115 RhoGEF, are restricted to the PNS fraction (Figure 1A)
[13]. Importantly, a significant amount of nuclear Net1 was
precipitated with nucleotide-free RhoA, indicating that Net1 is
indeed in an active form in the nucleus (Figure 1A). We estimate
that approximately 25% of all nuclear Net1 is active at steady
state. Another RhoA GEF, Ect2, is also precipitated with
nucleotide-free RhoA from the nuclear fraction, suggesting that
Ect2 is also present in an active form in the nucleus (Figure S1). To
our knowledge, this is the first demonstration of the Rho GEFs
Net1 and Ect2 being present in an active form in the nucleus of
cells.
Endogenous RhoA and multiple downstream signaling
partners are present in the nucleus of cells
We next investigated whether RhoA was also present in the
nucleus. While endogenous RhoA is predominantly localized to
the cytoplasm of HEK cells, a low amount of endogenous RhoA is
consistently detected in the nuclear fraction (Figure 1B). We
estimate that approximately 5% of total cellular RhoA is localized
to the nucleus of HEK cells at steady state. We have also tested
other cell lines, including HeLa, with similar results (not shown).
In addition to RhoA, the closely related RhoC, as well as Rac1
were also detected in the nucleus (Figure 1C). In contrast, Cdc42
was not detected in the nucleus even after long exposures
(Figure 1C). We also examined whether other upstream and
downstream components in the Rho signaling pathway, such as
RhoGAPs and effectors, were also present in the nucleus. While
some of the proteins involved in RhoA signaling pathways,
including the RhoA-GAP DLC1, p190 RhoGAP and the RhoA
effectors ROCK II/ROKa and LIMK, were detected in the
nucleus, others were not detected within the sensitivity of the
assay, (ROCK I/ROKb, mDia1, cofilin) (Figure 1D–E). We were
also able to detect actin in the nucleus, as has been reported before
by several groups (Figure 1E) [14]. From these data it is evident
that a subset of RhoA-associated proteins are present in the
nucleus, ranging from GEFs (Net1, Ect2), GAPs (DLC1, p190
RhoGAP) and GTPases (RhoA, RhoC, Rac1), to downstream
effector proteins (ROCK II, LIMK). These results therefore
highlight the potential of a functional nuclear Rho GTPase
signaling cascade.
RhoGDI1-binding restricts nuclear localization of RhoA
Previous studies have shown that the polybasic region (PBR) of
Rac1 is important for its nuclear localization [15,16]. The PBR of
RhoA interacts strongly with RhoGDI, an association that keeps
RhoA sequestered in the cytosol of cells and away from
membranes where it is active [5]. To determine whether the
interaction with Rho GDI might regulate the levels of RhoA in the
nucleus, we used siRNA to knockdown Rho GDI1 expression. As
we have recently described, RhoA protein level is drastically
reduced upon RhoGDI1 silencing (Figure 2A) [17]. However, the
amount of RhoA in the nuclear fraction increased significantly
despite the overall reduction in RhoA levels (Figure 2A–B). As
previously shown [17], the remaining pool of extranuclear RhoA is
mostly associated with membranes (Figure 2C). A similar result is
obtained when RhoGDI1 is silenced in cells that express GFP-
RhoA. Figure 2D shows that, in control cells the majority of GFP-
RhoA is diffusely distributed in the cytoplasm and regions
surrounding the nucleus. However, after RhoGDI1 knockdown,
the RhoA-GFP signal in the nucleus increases, with a concomitant
reduction of fluorescence in the cytoplasm. This result suggests
that RhoGDI1 may restrict the amount of RhoA that can be
targeted to the nucleus.
It has been previously shown that inhibition of prenylation by
statins or geranylgeranyl transferase inhibitors stabilizes the Rho
Net1-Mediated RhoA Signaling in the Nucleus
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levels [17,18]. In contrast to the results obtained with RhoGDI1
silencing, where RhoA is still prenylated and targeting to the
nucleus increased, inhibition of prenylation by lovastatin, showed
a decrease in the levels of nuclear RhoA suggesting that only
prenylated RhoA can be targeted efficiently to the nucleus
(Figure 2E).
Nuclear RhoA is in a GTP-bound active form, and is
regulated by Net1
We next wanted to determine if RhoA can exist in the nucleus
in a biologically active GTP-bound form. To do this, we developed
an assay to measure Rho-GTP levels from nuclear lysates based on
the Rho-binding domain (RBD) pulldown assays [19]. As seen in
Figure 3A, some nuclear RhoA is indeed in an active GTP-bound
form at steady state. To determine if Net1 regulates nuclear RhoA,
we first measured RhoA activity following overexpression of wild-
type myc-tagged Net1. Our results show a significant increase in
the nuclear activity of RhoA in Net1 overexpressing cells
suggesting Net1 can modulate the activity of the nuclear pool of
RhoA (Figure 3B–D). Supporting these results, silencing Net1
expression using siRNA oligonucleotides induces a significant
reduction in nuclear RhoA activity (Figure 3E–F). These data
indicate that the activity of nuclear RhoA can be regulated by
Net1.
IR treatment specifically increases activity of nuclear-
localized RhoA and Net1
We next wanted to investigate the biological importance of Net1
and RhoA signaling in the nucleus of cells. Previous studies have
Figure 1. The RhoA exchange factor Net1 is active in the nucleus. (A) Active GEF pulldowns with GST-RhoA(17A) were performed from PNS
and nuclear fractions of HEK293 cells, and the samples blotted with antibodies for the GEFs Net1 and p115 RhoGEF. (B) Samples were blotted for Na/
K ATPase (plasma membrane), Tubulin (cytosol), and Lamin to monitor the purity of the nuclear fractions (Bottom panel). (B–E) Total cell lysate, PNS
and nuclear fractions from HEK cells were immunoblotted for RhoA (B) to determine the amount of RhoA in the nucleus of cells, as well as other
GTPases (C). The purity of the nuclear fractions was verified by blotting for different marker proteins, including Na/K ATPase (plasma membrane),
Tubulin (cytosol), EEA1 (endosomes), and Lamin and PARP (nuclear) (B). Fractions were also blotted for a wide range of RhoA-related signaling
proteins including GAPs (D), effectors and downstream signaling proteins (E) to determine their presence or absence in the nucleus.
doi:10.1371/journal.pone.0017380.g001
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extracellular stimuli that cause DNA damage, such as IR [20].
Correspondingly, RhoA has also been shown to be activated in
response to DNA damaging agents [20,21]. However, both of
these studies investigated the activation of Net1 and RhoA from
total cellular pools. While it was hypothesized that active Net1
translocates from the nucleus to activate RhoA in the cytosol, this
has not been specifically demonstrated.
Since we observed that Net1 and RhoA are both active in the
nucleus, we wanted to determine whether the previously observed
IR-induced increase in RhoA and Net1 activity occurred in the
nucleus or in the cytoplasm. To do this, HEKs were either left
untreated, or irradiated, and RhoA activity assays performed from
isolated PNS and nuclear fractions. Interestingly, while the activity
of nuclear-localized RhoA increased significantly in response to IR
exposure, the activity of RhoA in the cytoplasm (PNS fraction) was
not affected (Figure 4A–B). In support of this data, we see no
major changes in the amount of stress fiber formation in response
to irradiation (Figure S2, A–B). The specific activation of nuclear
RhoA suggests that this subcellular pool of RhoA is important for
downstream activation of DNA damage signaling.
Similar to nuclear RhoA, the activity of nuclear Net1 was also
upregulated by IR while the activity in the cytoplasm (PNS fraction)
remained unchanged (Figure 4C–D). To determine if Net1 is
involved in the IR-induced increase in nuclear RhoA activity, we
silenced Net1 expression using siRNA oligonucleotides. Net1
knockdown cells displayed lower basal levels of active RhoA in
the nucleus than control cells, and failed to activate the nuclear
RhoA fraction in response to IR (Figure 4E–F). In contrast to the
results observed in nuclear RhoA activity, simultaneous analysis of
RhoA activity in the PNS fraction showed no significant effect by
Net1 silencing in either untreated or irradiated cells (Figure S2C).
Thesedatatherefore suggest that Net1isthemajorGEFresponsible
foractivating nuclear RhoA inresponseto a DNAdamagestimulus.
Figure 2. RhoGDI1 restricts nuclear localization of RhoA. (A) HEK293 cells were transfected with non-targeting control or Rho GDI1 siRNA
oligonucleotides. 72 hours post-transfection, nuclei were isolated and lysates blotted for RhoA, GDI1, tubulin and Lamin. (B) Quantification of nuclear
RhoA levels from three independent experiments is shown in the bar graph, as fold change over control cells. Asterisk indicate P=0.03. (C) Control or
RhoGDI1 siRNA-transfected cells, fractionated into cytosol (C) and membrane fractions (M), and blotted for RhoA, tubulin (cytosolic marker) and
transferrin receptor (TfR, membrane marker). (D) HeLa cells were transfected with non-targeting control or Rho GDI1 siRNA oligonucleotides.
48 hours after transfection, cells were transfected with GFP-RhoA. 24 hours later, cells were fixed and imaged for localization of GFP-RhoA.
Bar=10 mm. (E) HEK cells were treated with 2.5 nM lovastatin for 48 h. PNS and nuclear fractions collected as detailed above, and samples blotted for
RhoA, Lamin and Tubulin.
doi:10.1371/journal.pone.0017380.g002
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RhoA and Net1 are activated in the cytoplasm and shuttled into
the nucleus during the assay. To address this issue, we first isolated
nuclear fractions from HEK cells, subjected the isolated nuclei to
IR, and then performed RhoA and Net1 activity assays. Our
results show that both RhoA and Net1 can be activated by IR in
isolated nuclei in the absence of any signals from the cytoplasm
(Figure 5A–D). In addition, isolated nuclei failed to activate RhoA
following IR when Net1 expression was silenced (Figure 5E–F).
These results suggest that the components required for activation
of Net1 following IR are all present in the nucleus. In summary,
these results highlight a previously unappreciated role for Net1
activity in the nucleus of cells, and implicate Net1-RhoA nuclear
signaling in the biological response to DNA damage.
Discussion
Net1 and Ect2 are unique among RhoA GEFs in their
predominant localization to nuclei at steady-state. Another RhoA
GEF, XPLN, has also been seen in the nucleus, but this was only
determined by overexpression of a GFP-tagged XPLN construct
[22]. The functions of Net1 and Ect2 have been tied to different
biological processes: Net1 has been shown to be involved in
regulation of transforming growth factor-b and serum response
factor signaling [10,23], and Ect2 has been implicated in the
regulation of RhoA and Cdc42 in different cell cycle-related
processes [24,25,26]. However, no previous study has determined
the importance of nuclear localization of Net1, or if nuclear Net1
has a biological function. In this study we show that a significant
amount of Net1 is indeed active in the nucleus of different cell
types (Figure 1), contrary to studies that assumed nuclear Net1 was
biologically inactive.
In addition, we demonstrate that a small fraction of cellular
RhoA is present in the nucleus. Importantly, RhoA can be
detected in the nucleus in its GTP-bound active form, and its
activation state is regulated by Net1 (Figures 2 and 3). Other
GTPases are also present in the nucleus, like Rac1 and RhoC.
These data are supported by a previous report describing the
presence of Rac1, and to a lesser extent RhoA, in the nucleus [16].
Further, different RhoA signaling partners also localize to the
nucleus, including GAPs (DLC1, p190 RhoGAP) and effector
proteins (ROCK II, LIMK). Our data is supported by previous
reports describing the nuclear localization of these proteins
[27,28,29]. Activity of ROCK II in the nucleus has been shown
Figure 3. RhoA is active in the nucleus, and is regulated by Net1. (A) Nuclear lysates were incubated with GST-RBD (or GST alone as a control)
to precipitate active RhoA from the nucleus of HEK293 cells. Samples were then subjected to SDS-PAGE and blotted with an anti-RhoA antibody.
Samples were also blotted for Tubulin (cytosol), and Lamin to monitor the purity of the nuclear fractions (Bottom panel). (B) HEK cells were
transfected with wildtype myc-tagged Net1 or a control vector. 24 hours after transfection, nuclear lysates were isolated and GST-RBD pulldowns
performed. Samples were blotted for RhoA and exogenously expressed myc-Net1 (using an anti-myc antibody). (C) Samples in (B) were blotted for
Tubulin (cytosol), EEA1(endosome) and Lamin (nucleus) to monitor the purity of the nuclear fractions. (D) Quantification of nuclear RhoA activity from
three independent experiments is shown in the bar graph, as fold change over control cells. Asterisk indicate P=0.0001 (n=4). (E) HEK293 cells were
transfected with control siRNA or Net1-specific siRNA. 72 hours post transfection, nuclear lysates were isolated and GST-RBD pulldowns performed.
Samples were blotted for RhoA, Net1 and Lamin. (F) Quantification of nuclear RhoA activity from three independent experiments is shown in the bar
graph, as fold change over control cells. Asterisk indicate P=0.007 (n=3).
doi:10.1371/journal.pone.0017380.g003
Net1-Mediated RhoA Signaling in the Nucleus
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17380to regulate the phosphorylation and activation of p300 acetyl-
transferase [28]. ROCK phosphorylates and activates LIMK,
which has also been reported to be nuclear-localized [29]. While
we did not detect cofilin in the nucleus of HEK cells, it has been
reported in the nucleus by several groups [30,31]. However, cofilin
seems to accumulate in the nucleus only in cells exposed to specific
stress stimuli (such as ATP depletion or heat shock), suggesting that
cofilin may not normally have a nuclear localization in healthy
cells at steady state [30,31]. Not surprisingly, actin was also
detected in the nucleus, which has been previously implicated in
several different nuclear processes, such as transcription and
chromatin remodeling [14]. Interestingly, focal adhesion proteins
like zyxin and paxillin have also been found in the nucleus, where
they have been implicated in regulating the transcriptional
activities of specific genes [32,33,34]. Cumulatively, these data
highlight the presence of major Rho-related signaling processes in
the nucleus of cells, an area that has previously been neglected.
Previous studies have shown that the PBR of Rac1 and several
adjoining residues comprise a functional NLS that is responsible
for the nuclear localization of Rac1 [15,16]. Expression of
constructs expressing the PBRs of both Rac1 and RhoA tagged
to GFP showed that the PBRs of both proteins functioned as
NLSs, with the Rac1 PBR being a stronger NLS [35]. The PBR of
RhoA has been shown to strongly interact with Rho GDI1, an
Figure 4. IR causes an increase in nuclear RhoA activity through Net1. HEK293 cells were either left untreated or exposed to ionizing
radiation (10 Gy). After incubation at 37uC for 1 hr, PNS and nuclear fractions were isolated, and (A) RhoA and (C) GEF activity assays performed. The
samples were then blotted with antibodies for the indicated proteins. (E) HEK293 cells were transfected with control siRNA or Net1-specific siRNA.
72 hours post transfection, the cells were either left untreated or exposed to ionizing radiation (10 Gy). After incubation at 37uC for 1 hr, nuclear
fractions were isolated and Rho activity assays performed. Samples were subjected to SDS-PAGE and blotted with an anti-RhoA antibody. Samples
were also blotted with anti-Net1 and anti-Lamin antibodies to demonstrate the level of Net1 knockdown. (B, D and F) Quantification of nuclear
RhoA and Net1 activity from at least three independent experiments (n=3) are shown in the bar graphs, as fold change over control cells. Asterisks in
(B) indicate P=0.01 (n=6); in (D): P=0.04 (n=3); in (F): P=0.02, P=0.005 and P=0.0125 respectively (n=4).
doi:10.1371/journal.pone.0017380.g004
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Our results show that RhoA levels in the nucleus increase upon
knockdown of RhoGDI1, suggesting that binding to RhoGDI1
plays a role in modulating RhoA levels in the nucleus. Our results
suggest that nuclear RhoA is prenylated in agreement with a
previous report showing that nuclear Rac1 is also prenylated [16].
Previous studies have shown that Net1 is regulated via
phosphorylation by PAK1, which inhibits its exchange activity
[36]. IR was shown to cause a reduction in total phosphorylated
Net1, which is indicative of GEF activation [20]. This study also
showed that IR-induced Net1 activity was also responsible for
downstream activation of the MAPK pathway, leading to an
increase in cell survival [20]. An assumption of these experiments
was that active Net1 translocates from the nucleus to the cytosol,
where it can interact with and activate RhoA [20]. However, we
show here that IR specifically activates the nuclear pool of RhoA
(not the cytosolic pool), in addition to nuclear Net1 (Figure 4).
Importantly, Net1 is required for IR-induced nuclear RhoA
activity. These data demonstrate a novel role for Net1 in the
nucleus of cells, and implicate both nuclear Net1 and RhoA in
DNA damage signaling.
We have recently shown that Net1 interacts with several
members of the Dlg family of tumor suppressors via its PDZ-
binding domain [37]. Interestingly, Net1 colocalizes with these
Figure 5. IR promotes Net1-mediated RhoA activation in isolated nuclei. Nuclei were isolated from HEK293 cells, and either left untreated or
exposed to ionizing radiation (10 Gy). After IR, nuclei were immediately processed for (A) RhoA activity or (C) GEF activity assays, and samples blotted
for the indicated proteins. (E) HEK293 cells were transfected with control siRNA or Net1-specific siRNA. 72 hours post transfection; nuclei were
isolated, irradiated, processed for RhoA activity assays, and blotted with antibodies to Net1, RhoA and Lamin. (B, D and F) Quantification of nuclear
RhoA and Net1 activity in isolated nuclei are shown in the bar graphs, as fold change over control cells. Asterisk in (B) and (D) indicate P=0.04 (n=4)
and P=0.001 (n=3) respectively; n=2 in (F).
doi:10.1371/journal.pone.0017380.g005
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with promyelocytic leukemia (PML) bodies. PML nuclear bodies
are multiprotein complexes involved in regulating the cellular
response to DNA damage [38]. Localization of Net1 to PML
bodies is therefore consistent with this GEF contributing to the
signaling cascades initiated by DNA damage.
We also confirm that the signals required for activation of Net1
(and RhoA) are generated in the nucleus, as isolated nuclei
exposed to IR also show this effect (Figure 5). It is interesting to
speculate how Net1 might be activated in the nucleus of cells
responding to IR. Since phosphorylated Net1 is inactive [36], it is
likely that activation of Net1 involves dephosphorylation by a
phosphatase, which itself could be activated by several different
kinases stimulated by IR. A particularly interesting candidate is
Ataxia-telangiectasia mutated (ATM), a protein that plays a major
role in regulating the cellular response to DNA damage [21]. IR
triggers a rapid activation of ATM, which is responsible for
phosphorylating several different downstream targets involved in
cell cycle arrest and DNA repair [39,40]. Importantly, RhoA
activation in response to DNA damage was shown to be inhibited
in ATM deficient cells [21], suggesting that ATM may be involved
in the stimulation of Net1 by IR. Our future work will focus on
investigating the mechanisms by which Net1 is activated in
response to IR.
Materials and Methods
Cell Culture and Reagents
HEK293 and HeLa cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) (Invitrogen) supplemented with 10%
fetal bovine serum (FBS) (Sigma), and antibiotics (penicillin-
streptomycin). For inhibition of prenylation, HEK cells were
treated overnight with 2.5 nM lovastatin (Axxora).
Subcellular fractionation
To isolate pure nuclear fractions from whole cell lysates, cells
were first washed with Tris-buffered saline with 1 mM MgCl2, and
scraped in a hypotonic buffer (10 mM pH 7.9 Hepes, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT plus protease inhibitors).
After incubating 5 minutes on ice, samples are homogenized using
20 strokes of a tight-fitting Dounce homogenizer. An aliquot is
retained as the total cellular fraction. The homogenate was then
centrifuged at 4006 g for 3 min to produce a post nuclear
supernatant fraction (PNS) and a crude nuclear fraction (pellet).
The nuclear pellet was resuspended in a 30% iodixanol solution
(Optiprep, Axis Shield), and centrifuged at 12,0006g for 4 min.
This last centrifugation step was repeated a second time, and the
pellet obtained was used as a pure nuclear fraction. The obtained
total, PNS (cytoplasmic) and nuclear fractions were then processed
for pulldown experiments or microscopy. For cytosol (C) and
membrane (M) fractionation, the PNS fraction from the first low
speed centrifugation in the nuclear isolation protocol described
above was spun at 40,0006 g for 30 min at 4uC and the pellets
corresponding to the total membrane fraction, were gently washed
once with hypotonic lysis buffer. Typically, 5% of the cytosolic
fraction and 25% of the membrane fraction were analysed by
SDS–PAGE and western blotting.
RhoA and GEF activity assays
Construction of the GST-RBD and GST-RhoA(G17A) pro-
karyotic expression constructs and purification of the recombinant
proteins has been described in detail elsewhere [41,42]. Active
RhoA pulldown assays and affinity precipitation of exchange
factors with the nucleotide-free RhoA mutant (G17A) has been
described in detail in previous work [12,19]. For RhoA pulldowns,
samples (total, PNS or nuclear fractions) were reconstituted in
50 mM Tris (pH 7.6), 500 mM NaCl, 1% Triton X-100, 0.1%
SDS, 0.5% deoxycholate, 10 mM MgCl2, 200 mM orthovanadate
plus protease inhibitors, and sonicated briefly. Samples were
equalized for total protein concentrations, and rotated for 30 min
at 4uC with 30–60 mg of purified GST-tagged Rhotekin Rho-
binding domain (RBD) bound to glutathione-sepharose beads.
The bead pellets were washed in 50 mM Tris (pH 7.6), 150 mM
NaCl, 1% Triton X-100, 10 mM MgCl2, 200 mM orthovanadate,
with protease inhibitors, and subsequently processed for SDS-
PAGE.
For affinity precipitation of exchange factors, total, PNS or
nuclear fractions were reconstituted in 20 mM Hepes (pH 7.6),
150 mM NaCl, 1% Triton X-100, 5 mM MgCl2, 200 mM
orthovanadate plus protease inhibitors, and sonicated briefly.
Lysates were equalized for protein concentration and incubated
with 20 mg of purified GST-tagged RhoA(17A) bound to
glutathione-sepharose beads for 60 min at 4uC. Samples were
then washed with lysis buffer and processed for SDS-PAGE. For
IR experiments, HEK cells were either left untreated or exposed to
ionizing radiation (10 Gy), and then incubated at 37uC for 1 hr in
5% CO2. PNS and nuclear fractions were then isolated from these
cells, followed by either RBD or GEF pulldowns. For IR of
isolated nuclei, nuclear fractions from HEK cells were resus-
pended in 20 mM Tris-HCl, pH 7.8, 0.25 M Sucrose, 25 mM
KCl, 5 mM MgCl2, 1 mM ATP, 1 mM GTP and exposed to IR
(10 Gy). Following irradiation, nuclei were subjected to RhoA or
GEF activity assays.
Transfections and imaging
Transfection of HEK 293 and HeLa cells was performed using
FuGene6 Reagent, according to manufacturer’s instructions
(Roche). To determine purity of nuclear fractions, small aliquots
were resuspended in mounting medium containing 1 mg/ml
Hoechst to stain nuclear DNA. For F-actin staining, HeLa cells
were grown on coverslips, and subjected to irradiation (10 Gy).
The irradiated cells were incubated at 37uC for various time
points, and fixed and processed for immunofluoresence staining
with Alexa 488-Phalloidin. Quantitative analysis of stress fibers
was performed using Metamorph to measure the average
fluorescence intensity per cell in images that were serially acquired
using the same illumination and exposure parameters. Images
were taken with a Zeiss axiovert 200 M microscope equipped with
a Hamamatsu ORCA-ERAG digital camera and Metamorph
Workstation (Molecular Devices).
siRNA oligonucleotides
Control or targeted small interfering RNA (siRNA) oligonucle-
otides were purchased either from Dharmacon or the Nucleic
Acids Core Facility at UNC-Chapel Hill. The sequences were as
follows: control (59-UCACUCGUGCCGCAUUUCCTT-39), hu-
man Net1 (59-GAGUCUCCCUUCAGUCGAA-39), and human
GDI1 (59-UCAAUCUUGACGCCUUUCCTT-39). Transfection
of oligonucleotides was performed using TransIT-siQUEST
(Mirus Corporation) according to manufacturer’s instructions.
Western blotting
The following primary antibodies were used: anti-Lamin A/C,
anti-EEA1, anti-Rac1, anti-Cdc42, anti-ROCKI, anti-ROCKII,
anti-mDia1 (BD Transduction Laboratories), mouse monoclonal
anti-RhoA, anti-RhoC, anti-p115 RhoGEF, anti-Ect2, anti-GDI1
(Santa Cruz Biotechnology), anti-Cofilin, rabbit monoclonal anti-
RhoA and anti-PARP (Cell Signaling Technologies), anti-Actin,
Net1-Mediated RhoA Signaling in the Nucleus
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ATPase (Abcam) and anti-myc (Invitrogen). DLC1 antibodies
were a gift from Channing Der (UNC). A rabbit polyclonal
antibody against Net1 was made through Pacific Immunologicals,
using a peptide containing the last 18 amino acids of human Net1
(C-RRARDKALSGGKRKETLV). Quantification of all blots was
performed by densitometry using Image J software (NIH), and
represented in the bar graphs as fold increase over control cells
from three independent experiments. Error bars represent S.E.M.
Statistical differences between two groups of data were analysed
with a two-tailed unpaired Student’s t-test. To estimate the
amount of RhoA and active Net1 in the nucleus of cells, band
intensity of RhoA/Net1 in nuclear vs. total cellular fractions was
measured by densitometry, and the total amounts were calculated
based on the percentage of the total lysate loaded in the gel
followed by active/total ratio calculations.
Supporting Information
Figure S1 The RhoA GEF Ect2 is active in the nucleus of
cells. Active GEF pulldowns with GST-RhoA(17A) were
performed from PNS and nuclear fractions of HEK293 cells,
and the samples blotted with antibodies for the GEF Ect2.
(TIF)
Figure S2 IR does not affect cytosolic RhoA signaling.
(A) HeLa cells grown on coverslips were exposed to ionizing
radiation (10 Gy), and fixed after incubation at 37uC for the
indicated times. Cells were then stained with Alexa 488-Phalloidin
to visualize F-actin. (B) Stress Fibers were quantified as described
in Materials and Methods (n=180 for each time point). Bar=
10mM. (C) HEK293 cells were transfected with control siRNA or
Net1-specific siRNA. 72 hours post transfection, cells were either
left untreated or exposed to ionizing radiation (10 Gy). After IR,
cytosolic fractions were processed for RhoA activity assays and
blotted for RhoA and Tubulin. This experiment was done
simultaneously with the one shown in Figure 4E so the panel
showing the efficiency of Net1 KD is shown there. Quantification
of cytoplasmic (PNS) RhoA activity from three independent
experiments (n=3) is shown in the bar graph, as fold change over
control cells.
(TIF)
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